全文获取类型
收费全文 | 2638650篇 |
免费 | 195955篇 |
国内免费 | 19640篇 |
专业分类
耳鼻咽喉 | 36199篇 |
儿科学 | 79638篇 |
妇产科学 | 72992篇 |
基础医学 | 372527篇 |
口腔科学 | 73832篇 |
临床医学 | 248948篇 |
内科学 | 499420篇 |
皮肤病学 | 54515篇 |
神经病学 | 209427篇 |
特种医学 | 100338篇 |
外国民族医学 | 878篇 |
外科学 | 380442篇 |
综合类 | 86958篇 |
现状与发展 | 54篇 |
一般理论 | 898篇 |
预防医学 | 202184篇 |
眼科学 | 62290篇 |
药学 | 204462篇 |
164篇 | |
中国医学 | 16021篇 |
肿瘤学 | 152058篇 |
出版年
2021年 | 24534篇 |
2019年 | 24938篇 |
2018年 | 32733篇 |
2017年 | 26164篇 |
2016年 | 27570篇 |
2015年 | 33882篇 |
2014年 | 45809篇 |
2013年 | 63395篇 |
2012年 | 86631篇 |
2011年 | 92398篇 |
2010年 | 54834篇 |
2009年 | 50048篇 |
2008年 | 81637篇 |
2007年 | 86742篇 |
2006年 | 86759篇 |
2005年 | 84692篇 |
2004年 | 78215篇 |
2003年 | 74415篇 |
2002年 | 71906篇 |
2001年 | 115180篇 |
2000年 | 118818篇 |
1999年 | 101301篇 |
1998年 | 28430篇 |
1997年 | 25924篇 |
1996年 | 24598篇 |
1995年 | 24655篇 |
1994年 | 22944篇 |
1992年 | 77778篇 |
1991年 | 75841篇 |
1990年 | 73926篇 |
1989年 | 70984篇 |
1988年 | 65864篇 |
1987年 | 64555篇 |
1986年 | 61702篇 |
1985年 | 58602篇 |
1984年 | 43773篇 |
1983年 | 37355篇 |
1982年 | 22370篇 |
1979年 | 41050篇 |
1978年 | 29289篇 |
1977年 | 24672篇 |
1976年 | 23276篇 |
1975年 | 25237篇 |
1974年 | 30367篇 |
1973年 | 29632篇 |
1972年 | 27989篇 |
1971年 | 26088篇 |
1970年 | 24508篇 |
1969年 | 22999篇 |
1968年 | 21785篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
91.
92.
Hannah C. Nordhues Anjali Bhagra Natya N. Stroud Jennifer A. Vencill Carol L. Kuhle 《Mayo Clinic proceedings. Mayo Clinic》2021,96(7):1907-1920
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and health burdens along with overlapping vulnerabilities related to the pandemic. In addition, this review outlines recommended strategies that advocacy groups, community leaders, and policymakers should implement to mitigate the widening gender disparities related to COVID-19. 相似文献
93.
目的 分析10-MDP-钙盐形成对牙本质粘接成绩的影响。方法 采用酸蚀冲洗粘接模式,根据牙本质表面的处理方式和选择粘接剂的不同将牙齿随机分为以下4组(n=5)进行处理,制作牙本质/树脂粘接试件:①对照组,直接使用全酸蚀粘接剂Single bond 2(SB2)处理后粘接;②10-MDP组,使用SB2处理进行粘接前,牙本质表面以含有磷酸酯单体10-MDP的自配底涂剂预处理;③CHX组,使用SB2处理进行粘接前,先以氯己定(CHX)预处理牙本质表面;④SBU组,使用包含10-MDP的通用型粘接剂Single bond universal(SBU)处理后进行粘接。通过微拉伸测试(μTBS)测试粘接强度,以X射线衍射(XRD)、原位酶谱测试表征自配10-MDP底涂剂和两种牙本质粘接剂处理的牙本质表面,分析10-MDP-钙盐形成对牙本质粘接成绩的影响。结果 微拉伸结果显示,不同处理方式的粘接试件在24 h水储后没有表现出明显的统计学差异(P>0.1);经过6个月的水储后,与10-MDP组和SBU组相比,对照组的微拉伸强度显著降低(P<0.05),而CHX组的微拉伸强度没有明显变化(P>0.05)。XRD结果显示,在10-MDP组和SBU组均检测到10-MDP-钙盐形成的特征性峰,表明有10-MDP-钙盐的形成。原位酶谱结果显示,10-MDP组与SBU组之间混合层荧光强度没有明显区别,但均明显高于对照组,CHX组荧光强度低于10-MDP组与SBU组。结论 10-MDP-钙盐的形成能够保护暴露的胶原纤维不接触到MMPs而免于水解,从而增强牙本质/树脂的粘接成绩。 相似文献
94.
95.
96.
Heather L. Brown 《Journal of emergency nursing》2021,47(2):321-325
The coronavirus 2019 pandemic has affected almost every aspect of health care delivery in the United States, and the emergency medicine system has been hit particularly hard while dealing with this public health crisis. In an unprecedented time in our history, medical systems and clinicians have been asked to be creative, flexible, and innovative, all while continuing to uphold the important standards in the US health care system. To continue providing quality services to patients during this extraordinary time, care providers, organizations, administrators, and insurers have needed to alter longstanding models and procedures to respond to the dynamics of a pandemic. The Emergency Medicine Treatment and Active Labor Act of 1986, or EMTALA, is 1 example of where these alterations have allowed health care facilities and clinicians to continue their work of caring for patients while protecting both the patients and the clinicians themselves from infectious exposures at the same time. 相似文献
97.
98.
Yunbao Xu Mengting Zhang Jiaying Zhang Derry Minyao Ng Xiaoxiao Chen Yuexiu Si Yetan Shi Xiangyuan Li Danyi Mao Lu Yang 《Taiwanese journal of obstetrics & gynecology》2021,60(3):433-441
Cervical cancer is a global health challenge in women. Neoadjuvant chemotherapy (NACT) is a recent prospect for alternative cervical cancer treatments. This study investigated the efficacy of NACT against resectable cervical cancer based on the medium and long-term survival of patients with the disease. We searched through PubMed, Web of Science, EBSCO and Cochrane Library for relevant reports published by June 2020. The primary outcomes were 3-year and 5-year progression-free survival (PFS) and overall survival (OS) of patients with resectable cervical cancer. Overall, 22 publications encompassing 5627 patients fulfilled the inclusion criteria. We found NACT not to affect both 3-year PFS and OS as well as 5-year PFS of patients with resectable cervical cancer. However, NACT significantly improves the 5-year OS of patients with resectable cervical cancer (HR = 0.83, 95% CI: 0.73–0.94, p = 0.013). Subgroup analysis (RCTs, non-RCTs, NACT + surgery + AT vs. surgery + AT, NACT + surgery + AT vs. CCRT/RT/CRT) further revealed NACT had no significant effect on 5-year PFS of patients with resectable cervical cancer, converse to the 5-year OS subgroup analysis, which validated the beneficial effect of NACT in patients with resectable cervical cancer. In addition, the effect of NACT was most significant in the non-RCTs subgroup (p = 0.012). NACT may improve the long-term prognosis of patients with resectable cervical cancer. However, further large-scale multicenter studies are needed to validate this finding. 相似文献
99.
Tian-Chi Tsai Huan-Ka Chiung Liang-Hsuan Chen Hsien-Ming Wu 《Taiwanese journal of obstetrics & gynecology》2021,60(3):567-569
ObjectiveAssisted oocyte activation combined with ICSI (ICSI-AOA) has been reported to improve fertilization outcomes of couples with oocyte activation deficiency (OAD). Although there's no sufficient evidence to support ICSI-AOA as routine use, it might be beneficial for POSEIDON group 3 patients with suspected oocyte-related OAD.Case reportA 29-year-old female presented with a history of primary infertility for two years. She was classified as a POSEIDON group 3 patient and had a total fertilization failure history. With the help of ICSI-AOA, six oocytes were successfully fertilized. Pregnancy was later confirmed after embryo transfer. A living infant was born after 34 weeks of pregnancy.ConclusionOAD should be taken into consideration for POSEIDON group 3 patients since low Antimüllerian hormone is associated decreased quality. Further research needs to be done to understand the mechanism underlying oocyte-related OAD and the potential role of ICSI-AOA in young patients with suboptimal ovarian response. 相似文献
100.
目的 发现四物汤的新药理作用并辨识其有效成分群。方法 于GEO和Cmap数据库获取四物汤和1309个小分子药物的基因表达谱,计算差异表达基因及四物汤与1309个小分子药物的基因表达谱间的相似性,相似性较高的小分子药物的药理作用为四物汤的新药理作用。相似性较高的小分子药物的靶点作为四物汤发挥新药理作用的靶标,利用分子对接技术辨识四物汤的有效成分群。结果 四物汤具有抗乳腺癌的作用,其有效成分群为荭草苷、芍药苷和半乳糖醛酸等,并通过文献调研验证了辨识结果的可靠性。结论 本研究将为扩大四物汤的临床应用范围及质量控制奠定基础,为乳腺癌的治疗提供新方法。 相似文献